期刊
TUMOR BIOLOGY
卷 34, 期 6, 页码 3357-3361出版社
SPRINGER
DOI: 10.1007/s13277-013-0906-9
关键词
TCTP; Glioma; Biomarker; Prognosis
类别
资金
- State Key Development Program for Basic Research of China [2011CB503704]
- State Key Laboratory of Electrical Insulation and Power Equipment [EIPE12210]
- National Natural Science Foundation of China [81072272, 51277175, 31270899]
- International Science and Technology Cooperation Projects [2010DFA31900]
Upregulation of translationally controlled tumor protein (TCTP) has been reported in a variety of malignant tumors. However, the impact of TCTP in glioma remains unclear. The objective of this study was to investigate the expression and prognostic value of TCTP in glioma patients. Western blot analysis was used to characterize the expression patterns of TCTP in 45 glioma and 22 normal brain tissues. Immunohistochemistry on a tissue microarray containing 127 cases of glioma was performed to analyze the association between TCTP expression and clinicopathological features. Compared with normal brain tissues, TCTP expression was significantly higher in glioma tissues (p < 0.001). In addition, high TCTP expression in glioma was significantly associated with advanced pathological grade (p = 0.018). Kaplan-Meier analysis showed that patients with glioma and higher TCTP expression tend to have shorter overall survival time (p < 0.001). In multivariate analysis, TCTP expression was proved to be an independent prognostic factor for patients with glioma (p < 0.001). In conclusion, this study confirmed the overexpression of TCTP and its association with tumor progression in glioma. It also provided the first evidence that TCTP expression in glioma was an independent prognostic factor of patients, which might be a potential diagnostic and therapeutic target of glioma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据